Also listed on Novartis AG, an earlier holder on the record. The recorded assignments below show how it moved.
Term ended no later than Nov 8, 2026 · Medium confidence
20-year base term ended Nov 8, 2026
Nov 8, 2006
Nov 8, 2026
Aug 24, 2021
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 8, 2006, when application PCT/US2006/043710, the earliest non-provisional in its chain, was filed (this one was filed Sep 23, 2019) | Nov 8, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | no later than Nov 8, 2026 | Medium confidence |
This family
| Application PCT/US2006/043710 | PCT application no patent term | no patent term |
| US 8,877,938 | In force May 2027 | May 2027 |
| US 9,388,134 | Term ended Nov 2026 | Nov 2026 |
| Application 15/187,872 | Abandoned not computed | not computed |
| Application 16/006,252 | Abandoned not computed | not computed |
| Application 16/502,811 | Abandoned not computed | not computed |
| Application 16/502,821 | Abandoned not computed | not computed |
| US 11,096,918 | this patent no later than Nov 2026 | no later than Nov 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 10, 2019 Reel 50673, frame 179 | Feng, Lili; Godtfredsen, Sven Erik; Karpinski, Piotr; Sutton, Paul Allen; Prashad, Mahavir; Girgis, Michael J.; Hu, Bin; Liu, Yugang; Blackrock, Thomas J. | Novartis AG | Assignment of Assignor's Interest |
| Oct 10, 2019 Reel 50673, frame 199 | Novartis AG | Novartis Pharmaceuticals Corporation | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Nov 8, 2026. We will not guess the cap.